Information Provided By: 
Fly News Breaks for March 19, 2018
ZTS
Mar 19, 2018 | 07:48 EDT
As previously reported, Morgan Stanley downgraded Zoetis to Equal Weight from Overweight. Analyst David Risinger said shares are approaching his $87 price and now sees more balanced risk/reward.
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
